A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

NCT00134173 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Disease
Coronary Arteriosclerosis
Hyperlipidemia

Interventions

DRUG: torcetrapib/atorvastatin
DRUG: atorvastatin

Sponsor

Pfizer